If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Monica Capozzi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 21 Similar Profiles
Colorectal Neoplasms Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
HIV Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences
Meta-Analysis Medicine & Life Sciences
Neuroendocrine Tumors Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2015 2019

  • 99 Citations
  • 5 h-Index
  • 18 Article
  • 5 Review article
Open Access
Colorectal Neoplasms
Therapeutics
aflibercept
Bevacizumab
Survival

Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?

ICONA Foundation Study group, Oct 15 2019, In : BMC Public Health. 19, 1, p. 1-13 13 p., 1291.

Research output: Contribution to journalArticle

Open Access
Coinfection
Alcohol Drinking
Liver Diseases
HIV
Physicians
3 Citations (Scopus)

Lenvatinib, a molecule with versatile application: From preclinical evidence to future development in anti-cancer treatment

On behalf of ENETs (European NeuroEndocrine Tumor Society) Center of Excellence of Naples, Italy, Jan 1 2019, In : Cancer Management and Research. 11, p. 3847-3860 14 p.

Research output: Contribution to journalArticle

Open Access
Neoplasms
Thyroid Neoplasms
Receptor, Fibroblast Growth Factor, Type 3
Therapeutics
Vascular Endothelial Growth Factor Receptor

Safety and Activity of Metronomic Temozolomide in Second-Line Treatment of Advanced Neuroendocrine Neoplasms

Tafuto, S., von Arx, C., Capozzi, M., Tatangelo, F., Mura, M., Modica, R., Barretta, M. L., Di Sarno, A., Tornesello, M. L., Colao, A. & Ottaiano, A., Aug 15 2019, In : Journal of Clinical Medicine. 8, 8

Research output: Contribution to journalArticle

temozolomide
Safety
Neoplasms
Therapeutics
Dacarbazine